Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Mar;49(1):1-18.
doi: 10.1016/j.ecl.2019.10.009. Epub 2019 Dec 4.

Evolution of Diabetes Technology

Klemen Dovc  1 , Tadej Battelino  2
Affiliations
Free article
Review

Evolution of Diabetes Technology

Klemen Dovc et al. Endocrinol Metab Clin North Am. 2020 Mar.
Free article

Abstract

Technological innovations have fundamentally changed diabetes care. Insulin pump use and continuous glucose monitoring are associated with improved glycemic control along with a better quality of life; automated insulin-dosing advisors facilitate and improve decision making. Glucose-responsive automated insulin delivery enables the highest targets for time in range, lowest rate and duration of hypoglycemia, and favorable quality of life. Clear targets for time in ranges and a standard visualization of the data will help the diabetes technology to be used more efficiently. Decision support systems within and integrated cloud environment will further simplify, unify, and improve modern routine diabetes care.

Keywords: Artificial pancreas; Closed loop; Continuous glucose monitoring; Insulin pump; Multiple daily injections; Self-monitoring of blood glucose; Technology; Type 1 diabetes.

PubMed Disclaimer

Conflict of interest statement

Disclosure T. Battelino served on advisory boards of Novo Nordisk, Sanofi, Eli Lilly, Boehringer, Medtronic, and Bayer HealthCare. T. Battelino’s institution received research grant support, with receipt of travel and accommodation expenses in some cases, from Abbott, Medtronic, Novo Nordisk, GluSense, Sanofi, Sandoz, and Diamyd. K. Dovc declares that there is no duality of interest associated with his contribution to this article.

MeSH terms